774
Views
36
CrossRef citations to date
0
Altmetric
Original Research

Prevalence, awareness, and burden of major depressive disorder in urban China

, , &

References

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th Text Revision ed.). Washington (DC): American Psychiatric Association; 2000.
  • Blumenthal D, Hsiao W. Lessons from the east—China’s rapidly evolving health care system. N Engl J Med. 2015;372:1281–1285.
  • Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in mainland china: a systematic review. PLoS ONE. 2013;8:e65356. Gu et al. conducted a meta-analysis of studies published from 2000-2012 to determine the current, 12-month, and lifetime prevalence of MDD in China by sex and area of residence (rural vs. urban).
  • Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorder in four provinces in China during 2001-05: an epidemiological survey. Lancet. 2009;373:2041–2053.
  • Lu J, Ruan Y, Huang Y, et al. Major depression in Kunming: prevalence, correlates, and co-morbidity in a south-western city of China. J Affect Disord. 2008;111:221–226.
  • Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90.
  • Lee S, Tsang A, Huang YQ, et al. The epidemiology of depression in metropolitan China. Psychol Med. 2009;39:735–747.
  • Qin X, Wang W, Jin Q, et al. Prevalence and rates of recognition of depressive disorders in internal medicine outpatient departments of 23 general hospitals in Shenyang, China. J Affect Disord. 2008;110:46–54. Qin et al. conducted a large outpatients study showing that only 4.0% of depressed patients were diagnosed by a treating physician and only 3.0% were treated for depression.
  • Zhou X, Bi B, Zheng L, et al. The prevalence and risk factors for depression symptoms in a rural Chinese sample population. PLoS ONE. 2014;9:e99692. Zhou et al. found that the prevalence of MDD was high among rural residents, and respondents with more severe MDD symptoms reported poorer HRQoL than those with less severe or mild symptoms.
  • Yan Z, Gu M, Zhong B, et al. Prevalence, risk factors, and recognition rates of depressive disorders among inpatients of tertiary general hospitals in Shanghai, China. J Psychosom Res. 2013;75:65–71. Yan et al. found that, while MDD prevalence was high among hospital in-patients, psychiatrists accurately recognized MDD in less than 20% of those patients with current MDD symptoms.
  • Gan Z, Li Y, Xie D, et al. The impact of educational status on the clinical features of major depressive disorder among Chinese women. J Affect Disord. 2012;136:988–992.
  • Cao Y, Li W, Shen J, et al. Health-related quality of life and symptom severity in Chinese patients with major depressive disorder. Asia Pac Psychiatry. 2013;5:276–283. Cao et al. assessed MDD patients taking anti-depressants over six weeks and determined that more severe symptoms related to poorer HRQoL, but treatment improved these symptoms over baseline.
  • Zeng Q, Xu Y, Wang WC. Quality of life in outpatients with depression in China. J Affect Disord. 2013;150:513–521. Zeng et al. conducted a survey of over 20,000 out-patients with depression and found that depression symptoms were negatively associated with multiple dimensions of HRQoL.
  • Lee S, Tsang A, Huang Y, et al. Individual and societal impact on earnings associated with serious mental illness in metropolitan China. Psychiatry Res. 2010;180:132–136.
  • Hu TW, He Y, Zhang M, et al. Economic costs of depression in China. Soc Psychiatry Psychiatr Epidemiol. 2007;42:110–116.
  • Liao SC, Chen WJ, Lee MB, et al. Low prevalence of major depressive disorder in Taiwanese adults: Possible explanations and implications. Psychol Med. 2012;42:1227–1237.
  • Langley PC, Mu R, Wu M, et al. The impact of rheumatoid arthritis on the burden of disease in urban China. J Med Econ. 2011;14:709–719.
  • Goren A, Mould-Quevedo J, DiBonaventura M. Prevalence of pain reporting and associated health outcomes across emerging markets and developed countries. Pain Med. 2014;15:1880–1891.
  • DiBonaventura M, Liu GG, Stankus AP. Evidence for validity of a national patient-reported survey in China: the China National Health and Wellness Survey. Poster presented at: International Society for Pharmacoeconomics and Outcomes Research 5th Asia-Pacific Conference; September 2–4, 2012; Taipei (Taiwan)
  • Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157:1873–1875.
  • Cuellar AK, Johnson SL, Winters R. Distinctions between bipolar and unipolar depression. Clin Psychol Rev. 2005;25(3):307–339.
  • De Azevedo-Marques Périco C, Duran FL, Zanetti MV, et al. A population-based morphometric MRI study in patients with first-episode psychotic bipolar disorder: comparison with geographically matched healthy controls and major depressive disorder subjects. Bipolar Disord. 2011;13:28–40.
  • Zbozinek TD, Rose RD, Wolitzky-Taylor KB, et al. Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample. Depress Anxiety. 2012;29:1065–1071.
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
  • Je W Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
  • Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292.
  • Maruish ME. User’s manual for the SF-36v2 Health Survey. 3rd ed. Lincoln (RI): QualityMetric Incorporated; 2011.
  • Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–1532.
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–365.
  • Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Med. 2013;10(11):e1001547. doi:10.1371/journal.pmed.1001547
  • Wang PS, Angermeyer M, Borges G, et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s world mental health survey initiative. World Psychiatry. 2007;6:177–185.
  • Lam CS, Angell B, Tsang HWH, et al. Chinese lay theory and mental illness stigma: implication for research and practices. J Rehabil. 2010;76:35–40.
  • Mak WWS, Chen SX. Illness behaviors among the Chinese. In: Bond MH, Ed. Oxford Handbook of Chinese Psychology. New York (NY): Oxford University Press; 2010. p. 421–439.
  • Li N, Du W, Chen G, et al. Mental health service use among Chinese adults with mental disabilities: a national survey. Psychiatr Serv. 2013;64:638–644.
  • Yu X, Stewart SM, Wong PTK, et al. Screening for depression with the Patient Health Questionnaire-2 (PHQ-2) among the general population in Hong Kong. J Affect Disord. 2011;134:444–447.
  • Gong P, Liang S, Carlton EJ, et al. Urbanisation and health in China. Lancet. 2012;379:843–852.
  • Liu Q. Unemployment and labor force participation in urban China. China Econ Rev. 2012;23:18–33.
  • Chen Y, Wu KC, Yousuf S, et al. Suicide in Asia: opportunities and challenges. Epidemiol Rev. 2012;34:129–144.
  • Shen YC, Zhang MY, Huang YQ, et al. Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychol Med. 2006;36:257–267.
  • Guo WJ, Tsang A, Li T, et al. Psychiatric epidemiological surveys in China 1960-2010: how real is the increase of mental disorders? Curr Opin Psychiatry. 2011;24:324–330.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.